PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: SLU-PP-332
SLU-PP-332 is a synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRs) studied as an exercise mimetic that increases fat oxidation and endurance in animal models. It is a research chemical, not a peptide.
Sign in to rate this peptide.
SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors ERRalpha, ERRbeta, and ERRgamma, orphan nuclear receptors that govern mitochondrial biogenesis and oxidative metabolism. By activating ERRs, the compound up-regulates genes in the fatty-acid oxidation and oxidative phosphorylation programs, shifting cellular fuel use toward fat and increasing mitochondrial capacity in skeletal muscle. In rodent studies this drives a phenotype resembling endurance exercise, with greater running capacity, increased energy expenditure, and resistance to diet-induced obesity, hence the description as an exercise mimetic.